Angelo De Blasio

Alpha‐2a‐interferon/melphalan/prednisone versus melphalan/prednisone in previously untreated patients with multiple myeloma

A Montuoro, Luca De Rosa, Angelo De Blasio et al. · British Journal of Haematology · 1990 · 45 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia

Marco Montillo, Alessandra Tedeschi, Valeria Belsito Petrizzi et al. · Blood · 2011 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Why Say Sorry? Influencing Consumer Perceptions Post Organizational Crises

Angelo De Blasio, Roberta Veale · Australasian Marketing Journal (AMJ) · 2009 · 24 citations

Social Sciences, Communication, Strategy +16

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne et al. · Indian Heart Journal · 2018 · 21 citations · Full text

Medicine, Cardiology, Internal Medicine +10

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Sylvia Haas, A. John Camm, Harald Darius et al. · Clinical Research in Cardiology · 2022 · 12 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14